Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea

Antipathogenic Properties of Green Tea Polyphenol Epigallocatechin Gallate at Concentrations below the MIC against Enterohemorrhagic Escherichia coli O157:H7

(2016) KANG-MU LEE et al.   JOURNAL OF FOOD PROTECTION

(−)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus

(2012) Chao Chen et al.   ARCHIVES OF VIROLOGY

Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen

(2012) J. S. Brooke   CLINICAL MICROBIOLOGY REVIEWS

Tackling Human Fungal Infections

(2012) G. D. Brown et al.   SCIENCE

Antibacterial and Antifungal Activities of New Acylated Derivatives of Epigallocatechin Gallate

(2012) Yoshimi Matsumoto et al.   Frontiers in Microbiology

Digallate Dimers of (−)-Epigallocatechin Gallate Inactivate Herpes Simplex Virus

(2011) Charles E. Isaacs et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

AFM study of the differential inhibitory effects of the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) against Gram-positive and Gram-negative bacteria

(2011) Y. Cui et al.   FOOD MICROBIOLOGY

The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry

(2011) Sandra Ciesek et al.   HEPATOLOGY

(−)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry

(2011) Noémie Calland et al.   HEPATOLOGY

Epidemic Profile of Shiga-Toxin–ProducingEscherichia coliO104:H4 Outbreak in Germany

(2011) Christina Frank et al.   NEW ENGLAND JOURNAL OF MEDICINE

Induction and evasion of type I interferon responses by influenza viruses

(2011) Adolfo García-Sastre   VIRUS RESEARCH

Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line

(2011) Wei He   WORLD JOURNAL OF GASTROENTEROLOGY

In VitroAntifungal Activity of Epigallocatechin 3-O-Gallate against Clinical Isolates of Dermatophytes

(2011) Bong Joo Park et al.   YONSEI MEDICAL JOURNAL

The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors

(2010) Fan Jiang et al.   CLINICAL IMMUNOLOGY

Evolving epidemiology of hepatitis C virus

(2010) D. Lavanchy   CLINICAL MICROBIOLOGY AND INFECTION

Antimicrobial activity of the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) against clinical isolates of Stenotrophomonas maltophilia

(2010) Nicola C. Gordon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Staphylococcal strains adapted to epigallocathechin gallate (EGCG) show reduced susceptibility to vancomycin, oxacillin and ampicillin, increased heat tolerance, and altered cell morphology

(2010) Tamar Bikels-Goshen et al.   INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY

The effects of tea polyphenols on Candida albicans: inhibition of biofilm formation and proteasome inactivation

(2009) Nikki A. Evensen et al.   CANADIAN JOURNAL OF MICROBIOLOGY

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Highly antibiotic-resistant Acinetobacter baumannii clinical isolates are killed by the green tea polyphenol (–)-epigallocatechin-3-gallate (EGCG)

(2009) A. Osterburg et al.   CLINICAL MICROBIOLOGY AND INFECTION

Green tea inhibits Helicobacter growth in vivo and in vitro

(2009) Calin Stoicov et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Antiviral Effect of Epigallocatechin Gallate on Enterovirus 71

(2009) Hung-Yao Ho et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy

(2009) Christina L. Nance et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Herpes Simplex

(2009) P. Chayavichitsilp et al.   PEDIATRICS IN REVIEW

The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection

(2009) I. Hauber et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza

(2009) Nicolas Collin et al.   VACCINE

Epigallocatechin Gallate Inactivates Clinical Isolates of Herpes Simplex Virus

(2008) C. E. Isaacs et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro

(2008) Jun Xu et al.   ANTIVIRAL RESEARCH

Enhanced anti-influenza A virus activity of (−)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: Effect of alkyl chain length

(2008) Shuichi Mori et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Interaction of Tea Catechins with Lipid Bilayers Investigated by a Quartz-Crystal Microbalance Analysis

(2008) Miya KAMIHIRA et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Molecular Dynamics Study on the Biophysical Interactions of Seven Green Tea Catechins with Lipid Bilayers of Cell Membranes

(2008) Timothy W. Sirk et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Reaction Kinetics of Degradation and Epimerization of Epigallocatechin Gallate (EGCG) in Aqueous System over a Wide Temperature Range

(2008) Rong Wang et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells

(2008) J. Witteveldt et al.   JOURNAL OF GENERAL VIROLOGY

Mechanism of inhibition of wt-dihydrofolate reductase fromE. coliby tea epigallocatechin-gallate

(2008) Michele Spina et al.   PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS

Solid-state NMR analysis of the orientation and dynamics of epigallocatechin gallate, a green tea polyphenol, incorporated into lipid bilayers

(2007) Katsuko Kajiya et al.   MAGNETIC RESONANCE IN CHEMISTRY